RDY DR REDDYS LABORATORIES LTD
Price Chart
Executive Summary
Dr. Reddy's granted 1,192,234 stock options (816,119 Indian stock options + 376,115 ADR stock options) to eligible employees under existing ESOP schemes at an exercise price of Rs. 1,293.90 per share. This is a routine employee compensation event with no material financial impact or strategic significance.
Actionable Insight
Routine ESOP grant with no immediate trading implications. Monitor next quarterly filing for potential modest dilution impact from option exercises, though 3-year vesting makes this a distant consideration.
Key Facts
- Grant of 816,119 Indian stock options under Dr. Reddy's Employees Stock Option Scheme, 2018
- Grant of 376,115 ADR stock options under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
- Exercise price of Rs. 1,293.90 per share for both tranches
- 100% vesting at the end of 3 years for both option types
- Approved by Nomination, Governance and Compensation Committee on May 11, 2026
Financial Impact
No material financial impact — standard employee stock compensation grant with 3-year vesting; dilution is minimal relative to total shares outstanding
Risk Factors
- Minimal dilution risk from eventual option exercises over 3-year vesting period
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000280 |
| Document: 0001575872-26-000280-index.html | 0001575872-26-000280 |
| Document: 0001575872-26-000280.txt | 0001575872-26-000280 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 18, 2026
2d ago
|
6-K
| $13.57 awaiting T+5 | awaiting T+5 | — | $13.47 (−0.74%) |
|
May 18, 2026
3d ago
|
6-K
| — | awaiting T+5 | — | — |
|
May 15, 2026
5d ago
|
6-K
| $13.62 awaiting T+5 | awaiting T+5 | — | $13.47 (−1.10%) |
|
May 12, 2026
8d ago
|
6-K
| $12.99 $13.45 | ▲ +3.54% | ▲ +4.70% | $13.47 (+3.66%) |
|
May 12, 2026
8d ago
|
6-K
| $12.46 $13.60 | ▲ +9.15% | ▲ +9.07% | $13.47 (+8.07%) |
|
May 12, 2026
9d ago
|
6-K
| $12.46 $13.60 | ▲ +9.15% | ▲ +9.07% | $13.47 (+8.07%) |
|
May 12, 2026
9d ago
|
6-K
| $12.46 $13.60 | ▲ +9.15% | ▲ +9.07% | $13.47 (+8.07%) |
|
May 11, 2026
9d ago
|
6-K
| $13.14 $13.60 | ▲ +3.50% | ▲ +3.59% | $13.47 (+2.47%) |
|
Apr 29, 2026
22d ago
|
6-K
| — | awaiting T+5 | — | — |
|
Apr 24, 2026
27d ago
|
6-K
| $13.67 $13.64 | ▼ −0.22% | ▼ −1.13% | $13.47 (−1.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access